Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 20 studies | 57% ± 15% | |
lung | 18 studies | 62% ± 17% | |
intestine | 13 studies | 59% ± 24% | |
brain | 11 studies | 34% ± 11% | |
kidney | 9 studies | 61% ± 17% | |
eye | 9 studies | 42% ± 18% | |
bone marrow | 7 studies | 37% ± 18% | |
liver | 7 studies | 50% ± 22% | |
lymph node | 6 studies | 63% ± 16% | |
uterus | 5 studies | 65% ± 24% | |
prostate | 5 studies | 49% ± 23% | |
pancreas | 4 studies | 66% ± 25% | |
placenta | 4 studies | 68% ± 27% | |
breast | 4 studies | 71% ± 8% | |
heart | 3 studies | 30% ± 13% | |
adrenal gland | 3 studies | 53% ± 14% | |
esophagus | 3 studies | 65% ± 29% | |
skin | 3 studies | 50% ± 23% | |
thymus | 3 studies | 66% ± 26% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 9951.74 | 258 / 258 | 100% | 738.83 | 230 / 230 |
esophagus | 100% | 8128.04 | 1445 / 1445 | 100% | 310.56 | 183 / 183 |
liver | 100% | 9062.64 | 226 / 226 | 100% | 684.21 | 406 / 406 |
ovary | 100% | 9297.42 | 180 / 180 | 100% | 413.97 | 430 / 430 |
skin | 100% | 9114.72 | 1809 / 1809 | 100% | 548.08 | 472 / 472 |
thymus | 100% | 10901.09 | 653 / 653 | 100% | 915.15 | 605 / 605 |
brain | 100% | 8193.05 | 2640 / 2642 | 100% | 559.58 | 705 / 705 |
uterus | 100% | 7805.21 | 170 / 170 | 100% | 754.89 | 458 / 459 |
intestine | 100% | 8593.10 | 966 / 966 | 100% | 568.89 | 525 / 527 |
prostate | 100% | 11561.00 | 245 / 245 | 100% | 1076.36 | 500 / 502 |
pancreas | 100% | 9549.43 | 328 / 328 | 99% | 632.47 | 177 / 178 |
kidney | 100% | 9620.80 | 89 / 89 | 99% | 537.79 | 895 / 901 |
stomach | 100% | 7555.21 | 359 / 359 | 99% | 444.83 | 284 / 286 |
lung | 100% | 7256.30 | 578 / 578 | 99% | 469.90 | 1144 / 1155 |
bladder | 100% | 7337.62 | 21 / 21 | 99% | 613.47 | 498 / 504 |
breast | 100% | 8127.57 | 459 / 459 | 98% | 578.31 | 1099 / 1118 |
adipose | 100% | 7497.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 937.59 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 1181.41 | 29 / 29 |
spleen | 100% | 8019.95 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 729.61 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 800.35 | 1 / 1 |
blood vessel | 100% | 7907.74 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 6968.94 | 802 / 803 | 0% | 0 | 0 / 0 |
heart | 100% | 7257.63 | 858 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 5826.73 | 911 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019216 | Biological process | regulation of lipid metabolic process |
GO_0043388 | Biological process | positive regulation of DNA binding |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0045446 | Biological process | endothelial cell differentiation |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0001094 | Molecular function | TFIID-class transcription factor complex binding |
GO_0003677 | Molecular function | DNA binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | EDF1 |
Protein name | Endothelial differentiation-related factor 1 (EDF-1) (Multiprotein-bridging factor 1) (MBF1) |
Synonyms | |
Description | FUNCTION: Transcriptional coactivator stimulating NR5A1 and ligand-dependent NR1H3/LXRA and PPARG transcriptional activities. Enhances the DNA-binding activity of ATF1, ATF2, CREB1 and NR5A1. Regulates nitric oxid synthase activity probably by sequestering calmodulin in the cytoplasm. May function in endothelial cells differentiation, hormone-induced cardiomyocytes hypertrophy and lipid metabolism. . |
Accessions | ENST00000224073.6 [O60869-1] ENST00000371649.5 [O60869-3] O60869 ENST00000371648.4 [O60869-2] |